Related Experiment Video
Updated: May 31, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccine
J R Abbott1, M P Sanou, J K Coleman
1Department of Infectious Diseases and Pathology, College of Veterinary Medicine, University of Florida, P.O. Box 110880, Gainesville, FL 32611, USA.
Developing an effective human immunodeficiency virus type 1 (HIV-1) vaccine faces challenges in safety, defining protective immunity, and identifying key epitopes. Research in animal models, like feline immunodeficiency virus (FIV) studies, informs potential HIV-1 vaccine design strategies.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Human immunodeficiency virus type 1 (HIV-1) vaccine development remains a critical global health challenge.
- Understanding lentivirus infections in animal models offers insights into potential human vaccine strategies.
- Current HIV-1 vaccine trials face hurdles related to safety, immune response definition, and epitope identification.
Purpose of the Study:
- To review the current status of human HIV-1 vaccine trials.
- To compare HIV-1 vaccine approaches with those used in animal lentivirus models.
- To explore the potential of conserved T-cell epitopes in HIV-1 vaccine design.
Main Methods:
- Review of existing literature on HIV-1 vaccine trials.
- Comparative analysis of vaccines used in animal lentivirus infection models.
- Discussion of feline immunodeficiency virus (FIV) vaccine findings and HIV-1 protein immunization studies in cats.
Main Results:
- HIV-1 vaccine trials present safety considerations regarding vaccine composition.
- Defining and measuring protective immunity against HIV-1 is complex.
- Studies in cats using FIV vaccines and HIV-1 proteins provide valuable data.
Conclusions:
- Insights from animal lentivirus models, particularly FIV studies in cats, are crucial for advancing HIV-1 vaccine design.
- Evolutionarily conserved T-cell epitopes represent a promising avenue for future HIV-1 vaccine development.
- Addressing safety and immunological definition challenges is key to successful HIV-1 vaccine development.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Inhibitors of Virion Maturation and Assembly

